New drug for chronic hives begins first human safety tests
Knowledge-focused
Recruiting now
This early-stage trial tests the safety and tolerability of a new drug called HRS-3095 in 66 healthy adults aged 18-55. Researchers will also study how the drug moves through the body and how food affects it. The goal is to gather essential safety data before testing the drug in …
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC